Catalyst Wire Dossier Catalyst Wire Dossier

Fluorescein

fluorescein sodium
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Fluorescein, covering 2013-07-10 to 2025-08-03. Get the full timeline:

Most recent: Clinical Trial Update: Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker [Phase 2]

See pricing